0001328143-21-000063.txt : 20210608 0001328143-21-000063.hdr.sgml : 20210608 20210608173233 ACCESSION NUMBER: 0001328143-21-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210607 FILED AS OF DATE: 20210608 DATE AS OF CHANGE: 20210608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEMSKI MARTHA J CENTRAL INDEX KEY: 0001198230 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 211003165 MAIL ADDRESS: STREET 1: 7770 REGENTS ROAD SUITE 113-505 CITY: SAN DIEGO STATE: CA ZIP: 92122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 1000 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 wf-form4_162318792641400.xml FORM 4 X0306 4 2021-06-07 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001198230 DEMSKI MARTHA J C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2021-06-07 4 S 0 2000 5.17 D 8000 D Common Stock 13000 I Martha J. Demski U/D/T 10/1/1994, Martha J. Demski Trustee This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax obligations in connection with the vesting of the reporting person's director restricted stock awards. /s/ Christopher B. Prentiss, Attorney-in-fact 2021-06-08